PEPFAR and the Children’s Investment Fund Foundation have launched Accelerating Children’s HIV/AIDS Treatment (ACT), a $200 million initiative to double the number of children receiving ART in ten priority African countries in two years. Press Release» W.H. Release» W.H. Blog» Fact sheet»
PEPFAR is an important example of the successful collaboration between the U.S. and African nations. The shared commitment to save lives and change the course of the HIV/AIDS pandemic to achieve an AIDS-free generation was a key part of the discussion at the U.S.-Africa Leaders Summit. Learn More»
The target date for the Millennium Development Goals is just 500 days away. This provides the global health community an opportunity to take stock of what we are doing to advance the goals and build momentum for the new goals. Learn what PEPFAR is doing to advance the goals: Blog Post»
The International AIDS Conference is the world’s largest open scientific conference on HIV/AIDS. More about PEPFAR's participation in the 20th International AIDS Conference. Learn More» Storify Highlights» Photos» Blog» Video»
Ambassador Birx (July 24): "Today’s Medicines Patent Pool (MPP) announcement regarding the extension of its existing license with Gilead Sciences to include tenofovir alafenamide (TAF) is a promising step toward improving access to lifesaving HIV/AIDS treatment." Full text»
| U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator|
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA